Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
RESEARCH TOOLSreports
Total Valuation
AFT Pharmaceuticals Ltd. has a market cap or net worth of AU$274.82M. The enterprise value is ―.
Market CapAU$274.82M
Enterprise Value―
Share Statistics
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,866,260
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AFT Pharmaceuticals Ltd.’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 12.00%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)12.00%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee1.76M
Profits Per Employee141.90K
Employee Count110
Asset Turnover1.17
Inventory Turnover2.18
Valuation Ratios
The current PE Ratio of AFT Pharmaceuticals Ltd. is 20.20. AFT Pharmaceuticals Ltd.’s PEG ratio is -0.87.
PE Ratio20.20
PS Ratio0.00
PB Ratio3.46
Price to Fair Value3.59
Price to FCF10.89
Price to Operating Cash Flow11.27
PEG Ratio-0.87
Income Statement
In the last 12 months, AFT Pharmaceuticals Ltd. had revenue of 194.03M and earned 15.61M in profits. Earnings per share was 0.15.
Revenue194.03M
Gross Profit86.89M
Operating Income20.32M
Pretax Income22.02M
Net Income15.61M
EBITDA27.72M
Earnings Per Share (EPS)0.15
Cash Flow
In the last 12 months, operating cash flow was 25.75M and capital expenditures -190.00K, giving a free cash flow of 25.56M billion.
Operating Cash Flow25.75M
Free Cash Flow25.56M
Free Cash Flow per Share0.24
Dividends & Yields
AFT Pharmaceuticals Ltd. pays an annual dividend of AU$0.014, resulting in a dividend yield of 0.59%
Dividend Per ShareAU$0.014
Dividend Yield0.59%
Payout Ratio13.59%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.07
52-Week Price Change-7.14%
50-Day Moving Average2.41
200-Day Moving Average2.60
Relative Strength Index (RSI)61.14
Average Volume (3m)2.50K
Important Dates
AFT Pharmaceuticals Ltd. upcoming earnings date is Nov 20, 2025, TBA Not Confirmed.
Last Earnings DateMay 21, 2025
Next Earnings DateNov 20, 2025
Ex-Dividend DateJun 18, 2025
Financial Position
AFT Pharmaceuticals Ltd. as a current ratio of 2.30, with Debt / Equity ratio of 40.14%
Current Ratio2.30
Quick Ratio1.23
Debt to Market Cap0.09
Net Debt to EBITDA0.73
Interest Coverage Ratio5.51
Taxes
In the past 12 months, AFT Pharmaceuticals Ltd. has paid 6.41M in taxes.
Income Tax6.41M
Effective Tax Rate0.29
Enterprise Valuation
AFT Pharmaceuticals Ltd. EV to EBITDA ratio is 12.10, with an EV/FCF ratio of 17.35.
EV to Sales1.73
EV to EBITDA12.10
EV to Free Cash Flow17.35
EV to Operating Cash Flow11.62
Balance Sheet
AFT Pharmaceuticals Ltd. has AU$10.69M in cash and marketable securities with $33.64M in debt, giving a net cash position of AU$22.95M billion.
Cash & Marketable SecuritiesAU$10.69M
Total Debt$33.64M
Net CashAU$22.95M
Net Cash Per ShareAU$0.22
Tangible Book Value Per ShareAU$0.68
Margins
Gross margin is 44.60%, with operating margin of 10.47%, and net profit margin of 8.04%.
Gross Margin44.60%
Operating Margin10.47%
Pretax Margin11.35%
Net Profit Margin8.04%
EBITDA Margin14.29%
EBIT Margin13.25%
Analyst Forecast
The average price target for AFT Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―